The story
On October 10, 1962, President Kennedy signed the Kefauver-Harris Amendments to the Food, Drug, and Cosmetic Act. For the first time, drug makers had to prove to the Food and Drug Administration that a new drug was effective as well as safe, using 'adequate and well-controlled' studies. The law also required that people in experiments give informed consent, that side effects be reported, and that the FDA inspect drug factories.
Until then, the 1938 law, passed after a poisonous elixir killed more than 100 people, required only that a drug be shown safe before sale, and a drug could be marketed if the FDA did not object within 60 days. Senator Estes Kefauver of Tennessee had been investigating high drug prices and promotional claims since 1959, but his bill had been watered down and stalled. Then, in July 1962, newspapers reported that the FDA reviewer Frances Kelsey had stopped thalidomide from being sold in the United States, while it had caused thousands of birth defects overseas. Public alarm revived the bill, and it passed Congress without opposition.
The law reshaped drug development into the phased clinical trials system used today, from small safety trials to large controlled studies, building on the randomized trial pioneered with streptomycin in the 1940s. It also led the FDA to review the effectiveness of thousands of drugs already on the market, known as the DESI program, and some were withdrawn. Critics later argued that the longer testing raised costs and delayed new treatments, an argument that continues in debates over speed of approval.
Why it mattered
- The randomized, controlled trial became the legal standard for proving a drug works, shaping modern evidence-based medicine.
- Informed consent for research subjects became U.S. law, preceding later rules after the Tuskegee study came to light.
- The FDA reviewed the effectiveness of thousands of older drugs, pulling ineffective ones from the market.
- Other countries tightened their own drug approval systems after the same scandal.
- The longer, costlier approval process created lasting debate over the balance between safety and speed.
Sources
- Promoting Safe & Effective Drugs for 100 Years FDA
- The Woman Who Stood Between America and an Epidemic of Birth Defects Smithsonian Magazine
- Thalidomide Science Museum
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…